title: Use of cheaper eye drug would save billions, says US study.
authors.affiliation: Seattle.
authors.forename: Michael
authors.initials: M
authors.lastname: McCarthy
mesh_terms: D020533:Angiogenesis Inhibitors / Q000191:economics* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000191:economics* / Q000627:therapeutic use; D000068258:Bevacizumab; D017046:Cost Savings; D003365:Costs and Cost Analysis; D006801:Humans; D000069579:Ranibizumab; D012162:Retinal Degeneration / Q000188:drug therapy / Q000191:economics*; D014481:United States
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D000069579:Ranibizumab